Growth Metrics

Usana Health Sciences (USNA) Gross Profit (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Gross Profit for 17 consecutive years, with $176.8 million as the latest value for Q1 2026.

  • Quarterly Gross Profit rose 0.99% to $176.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $724.4 million through Jan 2026, up 4.49% year-over-year, with the annual reading at $724.4 million for FY2026, 4.49% up from the prior year.
  • Gross Profit for Q1 2026 was $176.8 million at Usana Health Sciences, up from $164.9 million in the prior quarter.
  • The five-year high for Gross Profit was $294.5 million in Q1 2022, with the low at $161.0 million in Q3 2024.
  • Average Gross Profit over 5 years is $191.8 million, with a median of $184.7 million recorded in 2024.
  • The sharpest move saw Gross Profit plummeted 38.37% in 2022, then rose 7.61% in 2025.
  • Over 5 years, Gross Profit stood at $181.5 million in 2022, then fell by 1.52% to $178.8 million in 2023, then decreased by 2.07% to $175.1 million in 2024, then dropped by 5.83% to $164.9 million in 2025, then grew by 7.24% to $176.8 million in 2026.
  • According to Business Quant data, Gross Profit over the past three periods came in at $176.8 million, $164.9 million, and $185.7 million for Q1 2026, Q3 2025, and Q2 2025 respectively.